KRAS and neoplasm: To further validate the role of circPTK2 signaling cascade in metastatic potential in tumor stroma were treated metastatic H1299 and H1975 lung cells with si-circPTK2 and Kras/M2 inhibitors and subjected them to invasion or migration analysis respectively (Fig. 6F,G).